TFEB and lung carcinoma: In an in vivo setting, β-ELE demonstrates significant tumor growth inhibition, an effect compromised in the absence of TFEB, reinforcing the crucial role of TFEB in mediating β-ELE-induced anticancer responses in lung cancer [32].